[Muneaki Kurimura, Shinichi Taira, Takahiro Tomoyasu, Nobuaki Ito, Kuninori Tai, Noriaki Takemura, Takayuki Matsuzaki, Yasuhiro Menjo, Shin Miyamura, Yohji Sakurai, Akihito Watanabe, Yasuyo Sakata, Takumi Masumoto, Kohei Akazawa, Haruhiko Sugino, Naoki Amada, Satoshi Ohashi, Tomoichi Shinohara, Hirofumi Sasaki, Chisako Morita, Junko Yamashita, Satoko Nakajima] JP Tokushima The present invention provides a pyrrolidine compound of General Formula (1)or a salt thereof, wherein R101 and R102 are each independently a phenyl group or a pyridyl group, the phenyl group or the pyridyl group may have one or more substituents selected from halogen atoms and lower alkyl groups optionally substituted with one or more halogen atoms, etc. The pyrrolidine compound or a salt thereof of the present invention is usable to produce a pharmaceutical preparation having a wider therapeutic spectrum and being capable of exhibiting sufficient therapeutic effects after short-term administration.

[Mizuki Sugino, Satoshi Nakamura, Haruhiko Nishida, Masataka Konishi] JP Kanagawa A fixing device includes a rotatable pressure member; a heating member that is provided so as to oppose the pressure member, and that includes a heat source; a fixing member that fixes an image to a recording medium as a result of transporting the recording medium while the recording medium is nipped at a nip when the fixing member is pressed by the pressure member, the image being formed of toner including a separating agent; a cooling unit that cools the pressure member at a location that is situated downstream of the nip; a removing roller that, while being driven and rotated by the pressure member, removes the separating agent from the pressure member, the separating agent being transferred from the fixing member; and a removing member that contacts the removing roller and removes the separating agent adhered to the removing roller from the removing roller.

[KURIMURA, Muneaki, TAIRA, Shinichi, TOMOYASU, Takahiro, ITO, Nobuaki, TAI, Kuninori, TAKEMURA, Noriaki, MATSUZAKI, Takayuki, MENJO, Yasuhiro, MIYAMURA, Shin, SAKURAI, Yohji, WATANABE, Akihito, SAKATA, Yasuyo, MASUMOTO, Takumi, AKAZAWA, Kohei, SUGINO, Haruhiko, AMADA, Naoki, OHASHI, Satoshi, SHINOHARA, Tomoichi, SASAKI, Hirofumi, MORITA, Chisako, YAMASHITA, Junko, NAKAJIMA, Satoko] 9, Kanda-Tsukasamachi 2-chome, Chiyoda-ku, Tokyo 1018535;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 224-18, Ebisuno, Hiraishi, Kawauchi-cho, Tokushima-shi, Tokushima 7710182;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192;c/o OTSUKA PHARMACEUTICAL CO., LTD., 463-10, Kagasuno, Kawauchi-cho, Tokushima-shi, Tokushima 7710192 The present invention provides a pyrrolidine compound of General Formula (1) or a salt thereof, wherein R101 and R102 are each independently a phenyl group or a pyridyl group, the phenyl group or the pyridyl group may have one or more substituents selected from halogen atoms and lower alkyl groups optionally substituted with one or more halogen atoms, etc. The pyrrolidine compound or a salt thereof of the present invention is usable to produce a pharmaceutical preparation having a wider therapeutic spectrum and being capable of exhibiting sufficient therapeutic effects after short-term administration.

[Muneaki Kurimura, Shinichi Taira, Takahiro Tomoyasu, Nobuaki Ito, Kuninori Tai, Noriaki Takemura, Takayuki Matsuzaki, Yasuhiro Menjo, Shin Miyamura, Yohji Sakurai, Akihito Watanabe, Yasuyo Sakata, Takumi Masumoto, Kohei Akazawa, Haruhiko Sugino, Naoki Amada, Satoshi Ohashi, Tomoichi Shinohara, Hirofumi Sasaki, Chisako Morita, Junko Yamashita, Satoko Nakajima] JP Tokushima The present invention provides a pyrrolidine compound of General Formula (1)or a salt thereof, wherein R101 and R102 are each independently a phenyl group or a pyridyl group, the phenyl group or the pyridyl group may have one or more substituents selected from halogen atoms and lower alkyl groups optionally substituted with one or more halogen atoms, etc. The pyrrolidine compound or a salt thereof of the present invention is usable to produce a pharmaceutical preparation having a wider therapeutic spectrum and being capable of exhibiting sufficient therapeutic effects after short-term administration.

[Muneaki Kurimura, Shinichi Taira, Takahiro Tomoyasu, Nobuaki Ito, Kuninori Tai, Noriaki Takemura, Takayuki Matsuzaki, Yasuhiro Menjo, Shin Miyamura, Yohji Sakurai, Akihito Watanabe, Yasuyo Sakata, Takumi Masumoto, Kohei Akazawa, Haruhiko Sugino, Naoki Amada, Satoshi Ohashi, Tomoichi Shinohara, Hirofumi Sasaki, Chisako Morita, Junko Yamashita, Satoko Nakajima] JP Tokushima The present invention provides a pyrrolidine compound of General Formula (1)or a salt thereof, wherein R101 and R102 are each independently a phenyl group or a pyridyl group, the phenyl group or the pyridyl group may have one or more substituents selected from halogen atoms and lower alkyl groups optionally substituted with one or more halogen atoms, etc. The pyrrolidine compound or a salt thereof of the present invention is usable to produce a pharmaceutical preparation having a wider therapeutic spectrum and being capable of exhibiting sufficient therapeutic effects after short-term administration.